Lifelong Wellness: Product innovation and multisystemic approaches to aging

Lifelong Wellness: Product innovation and multisystemic approaches to aging

Lifelong Wellness: Product innovation and multisystemic approaches to aging

Tuesday, September 24, 2019 – 5:30 – 7:00 pm

5:00 pm Doors open

5:30 - 7:00 pm Symposium

7:00 - 8:00 pm delve Launch Reception to follow

McGill Faculty Club Ballroom, 3450 McTavish St., Montreal, Quebec H3A 1X9

With recent scientific advances, aging is no longer simply a normal consequence of a life well lived or and a path to death through painful and costly chronic diseases. Increasingly, it is seen as a process that can be managed by extending years of healthy lifestyle and containing ever-increasing healthcare costs.

Join Laurette Dubé, Professor of Marketing and Director of the McGill Centre for the Convergence of Health and Economics, in conversation with Dr. Mehmood Khan, scientist and former Vice Chairman of PepsiCo turned CEO of Life Biosciences Inc., a healthy living startup with more than $75 million in venture funding.

They will explore how the scientific community is partnering with business leaders, policymakers, and educators in an attempt to stave off multiple diseases of aging through integrated interventions and product innovation ranging from food and pharmaceuticals to bio technologies encompassing the end-to-end value chain from the consumer to retailer.


Dr. Mehmood Khan:

Mehmood Khan, M.D., is Chief Executive Officer and Board Member of Life Biosciences Inc. In his role as CEO, Dr. Khan provides strategic direction and operational oversight across Life Biosciences and its six daughter companies. His vision of a more efficient and effective drug development pathway will drive innovation in the science and technology Life Biosciences advances and for it to emerge as a global leader in longevity research and product development.

He also serves as Chair, U.S. Council on Competitiveness in Washington DC and Chair of the U.S. Pakistan Business Council. Dr. Khan is a member of the Board of Directors of Reckitt Benckiser, Indigo Ag, the Foundation for Food and Agricultural Research at the U.S. Department of Agriculture.

Dr. Khan previously served as Vice Chairman and Chief Scientific Officer of Global Research and Development at PepsiCo, a Fortune 50 company employing upwards of 250,000 employees across 22 brands. At PepsiCo, Dr. Khan played a pivotal role in the company’s global R&D efforts to create breakthrough innovations in food, beverages, and nutrition, including the incorporation of healthier and more nutritious offerings across its portfolio. Dr. Khan also oversaw PepsiCo's global sustainability initiatives based on the belief that success in business is inextricably linked to the sustainability of the world we share. Prior to joining PepsiCo, Dr. Khan served as President of Global R&D at Takeda Pharmaceuticals, leading the global efforts of one of the largest pharmaceutical companies in the world by revenue.

Before moving into industry, Dr. Khan had a distinguished medical career as a faculty member in endocrinology at the Mayo Clinic and Mayo Medical School where he served as Director of the Diabetes, Endocrine and Nutritional Trials Unit. He also spent nine years leading programs in diabetes, endocrinology, metabolism and nutrition for the Hennepin County Medical Center in Minneapolis.Dr. Khan earned his medical degree from the University of Liverpool Medical School, England, and completed a fellowship in clinical endocrinology and nutrition in the Department of Medicine and Food Science and Nutrition at the University of Minnesota, Minneapolis. He is a Fellow of the Royal College of Physicians, London and a Fellow of the American College of Endocrinology.

Laurette Dubé: Originally trained as a nutritionist, with graduate degrees in finances (MBA), marketing (MPS), and behavioral decision making/consumer psychology (PhD), Laurette Dubé is Full Professor and holds the James McGill Chair of consumer and lifestyle psychology and marketing at the Desautels Faculty of Management of McGill University. Dr. Dubé’s lifetime research interest bears on the study of affects, behavioral economics, and neurobehavioral processes underlying consumption, lifestyle, and health behavior. Her translational research examines how such knowledge can inspire more effective behavioral change and ecosystem transformation.

Dr. Dubé received the YMCA Women of Distinction Award for the social sciences in 2011 and the Queen Elizabeth II Diamond Jubilee Medal in 2013. She is a Fellow of the Royal Society of Canada.

Dr. Dubé is also the founding chair and scientific director of the McGill Center for the Convergence of Health and Economics (MCCHE). With a strong focus on harnessing the power of business as a catalyst for real-world change, the MCCHE operates through collaboration of private sector organizations with NGO/social enterprises, policymakers and academics at community, state, national and global levels to promote convergence through local and systemic changes. Behavioral economics, decision neuroscience, spatial-temporal statistics, and computational systems science models are at the core of real-time learning enabled by this transdisciplinary research-action approach.

Beyond books and scientific publications in the leading scientific journals, her work has been covered in Maclean’s, The Globe and Mail, USA Today, The Wall Street Journal, The Atlantic, and The Economist.

Coronavirus (COVID-19)

Get the latest Covid-19 updates and learn what to expect for McGill’s return to campus this Fall, 2021.

For Desautels specific updates please visit our COVID-19 FAQ page.

Back to top